rs13414203

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001365536.1(SCN9A):​c.1119T>C​(p.Ala373Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.386 in 1,588,578 control chromosomes in the GnomAD database, including 119,439 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11116 hom., cov: 31)
Exomes 𝑓: 0.39 ( 108323 hom. )

Consequence

SCN9A
NM_001365536.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.08

Publications

21 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 2-166288632-A-G is Benign according to our data. Variant chr2-166288632-A-G is described in ClinVar as Benign. ClinVar VariationId is 130254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 10 of 15 1 ENSP00000413212.2 A0A0C4DG82
SCN9AENST00000452182.2 linkc.1119T>C p.Ala373Ala synonymous_variant Exon 11 of 11 1 ENSP00000393141.2 H7C064

Frequencies

GnomAD3 genomes
AF:
0.381
AC:
57848
AN:
151844
Hom.:
11120
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.318
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.310
Gnomad SAS
AF:
0.357
Gnomad FIN
AF:
0.414
Gnomad MID
AF:
0.247
Gnomad NFE
AF:
0.403
Gnomad OTH
AF:
0.368
GnomAD2 exomes
AF:
0.367
AC:
88292
AN:
240754
AF XY:
0.368
show subpopulations
Gnomad AFR exome
AF:
0.377
Gnomad AMR exome
AF:
0.273
Gnomad ASJ exome
AF:
0.357
Gnomad EAS exome
AF:
0.316
Gnomad FIN exome
AF:
0.416
Gnomad NFE exome
AF:
0.395
Gnomad OTH exome
AF:
0.371
GnomAD4 exome
AF:
0.386
AC:
554591
AN:
1436616
Hom.:
108323
Cov.:
34
AF XY:
0.385
AC XY:
274355
AN XY:
712816
show subpopulations
African (AFR)
AF:
0.376
AC:
12326
AN:
32772
American (AMR)
AF:
0.279
AC:
12056
AN:
43192
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
8972
AN:
25372
East Asian (EAS)
AF:
0.306
AC:
12064
AN:
39422
South Asian (SAS)
AF:
0.355
AC:
29127
AN:
82080
European-Finnish (FIN)
AF:
0.417
AC:
21948
AN:
52688
Middle Eastern (MID)
AF:
0.305
AC:
1721
AN:
5644
European-Non Finnish (NFE)
AF:
0.396
AC:
433924
AN:
1096214
Other (OTH)
AF:
0.379
AC:
22453
AN:
59232
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
15857
31714
47570
63427
79284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13630
27260
40890
54520
68150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.381
AC:
57869
AN:
151962
Hom.:
11116
Cov.:
31
AF XY:
0.378
AC XY:
28043
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.379
AC:
15726
AN:
41454
American (AMR)
AF:
0.318
AC:
4842
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1235
AN:
3468
East Asian (EAS)
AF:
0.310
AC:
1597
AN:
5146
South Asian (SAS)
AF:
0.356
AC:
1716
AN:
4814
European-Finnish (FIN)
AF:
0.414
AC:
4367
AN:
10556
Middle Eastern (MID)
AF:
0.259
AC:
76
AN:
294
European-Non Finnish (NFE)
AF:
0.403
AC:
27379
AN:
67972
Other (OTH)
AF:
0.367
AC:
773
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1856
3712
5567
7423
9279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.389
Hom.:
9771
Bravo
AF:
0.372
Asia WGS
AF:
0.352
AC:
1231
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 24, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 41. Only high quality variants are reported. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Inherited Erythromelalgia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary erythromelalgia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Channelopathy-associated congenital insensitivity to pain, autosomal recessive Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal extreme pain disorder Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
10
DANN
Benign
0.76
PhyloP100
1.1
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13414203; hg19: chr2-167145142; COSMIC: COSV57621345; API